NYSE:JNJ
Johnson & Johnson
- Stock
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Broadhurst Vanessa EVP, Global Corp Affairs Common Stock | 2024-03-13 | -8.89K −37.15% |
Schmid Timothy EVP, WW Chair, MedTech Common Stock | 2024-02-15 | 249 1.95% |
Broadhurst Vanessa EVP, Global Corp Affairs Common Stock | 2024-02-15 | 199 0.84% |
Decker Robert J VP Corporate Controller Common Stock | 2024-02-15 | 227 1.21% |
Wolk Joseph J Exec VP, CFO Common Stock | 2024-02-15 | 1.01K 1.48% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Gorsky Alex Director Common Stock | 2022-01-19 | 68.37K 14.35% |
Duato Joaquin Vice Chair, Exec Committee Common Stock | 2020-02-18 | 61.76K 53.85% |
Gorsky Alex Chairman, CEO Common Stock | 2020-02-18 | 61.55K 15.80% |
Gorsky Alex Chairman, CEO Common Stock | 2019-02-12 | 52.90K 15.72% |
Gorsky Alex Chairman, CEO Common Stock | 2021-02-17 | 43.40K 10.03% |
Transaction Log
| Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
|---|---|---|---|---|---|---|---|---|
2024-03-13 | 2024-03-13 | Broadhurst Vanessa | EVP, Global Corp Affairs | 15.04K | 8.89K | S | Common Stock | -1.44M |
2024-02-15 | 2024-02-13 | Fasolo Peter | Exec VP, Chief HR Officer | 112.55K | 925 | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Forminard Elizabeth | Executive VP, General Counsel | 8.58K | 651 | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Fasolo Peter | Exec VP, Chief HR Officer | 112.08K | 474 | F | Common Stock | -74.82K |
2024-02-15 | 2024-02-13 | Swanson James D. | EVP, CIO | 14.57K | 195 | F | Common Stock | -30.78K |
2024-02-15 | 2024-02-13 | Hait William | See Remarks | 39.07K | 834 | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Swanson James D. | EVP, CIO | 14.77K | 447 | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Decker Robert J | VP Corporate Controller | 19.06K | 313 | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Wolk Joseph J | Exec VP, CFO | 69.66K | 1.78K | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Wolk Joseph J | Exec VP, CFO | 68.89K | 773 | F | Common Stock | -122.02K |
2024-02-15 | 2024-02-13 | Duato Joaquin | CEO and Chairman of the Board | 363.30K | 1.51K | F | Common Stock | -237.88K |
2024-02-15 | 2024-02-13 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 155.52K | 1.30K | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Hait William | See Remarks | 38.65K | 427 | F | Common Stock | -67.40K |
2024-02-15 | 2024-02-13 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 154.85K | 666 | F | Common Stock | -105.13K |
2024-02-15 | 2024-02-13 | Broadhurst Vanessa | EVP, Global Corp Affairs | 23.93K | 209 | F | Common Stock | -32.99K |
2024-02-15 | 2024-02-13 | Broadhurst Vanessa | EVP, Global Corp Affairs | 24.14K | 408 | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 82.27K | 333 | F | Common Stock | -52.56K |
2024-02-15 | 2024-02-13 | Schmid Timothy | EVP, WW Chair, MedTech | 13.04K | 250 | F | Common Stock | -39.46K |
2024-02-15 | 2024-02-13 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 82.60K | 651 | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Duato Joaquin | CEO and Chairman of the Board | 364.81K | 3.47K | M | Common Stock | 0 |
2024-02-15 | 2024-02-13 | Forminard Elizabeth | Executive VP, General Counsel | 8.34K | 236 | F | Common Stock | -37.25K |
2024-02-15 | 2024-02-13 | Decker Robert J | VP Corporate Controller | 18.97K | 86 | F | Common Stock | -13.58K |
2024-02-15 | 2024-02-13 | Schmid Timothy | EVP, WW Chair, MedTech | 13.29K | 499 | M | Common Stock | 0 |
2024-02-13 | 2024-02-09 | Duato Joaquin | CEO and Chairman of the Board | 340.62K | 98.66K | F | Common Stock | -15.47M |
2024-02-13 | 2024-02-09 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 75.20K | 27.33K | F | Common Stock | -4.28M |
2024-02-13 | 2024-02-09 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 102.53K | 35.64K | M | Common Stock | 3.22M |
2024-02-13 | 2024-02-09 | Duato Joaquin | CEO and Chairman of the Board | 439.28K | 130.97K | M | Common Stock | 11.84M |
2024-02-12 | 2024-02-08 | Forminard Elizabeth | Executive VP, General Counsel | 6.46K | 979 | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Hait William | See Remarks | 33.38K | 1.11K | F | Common Stock | -174.00K |
2024-02-12 | 2024-02-08 | Schmid Timothy | EVP, WW Chair, MedTech | 9.94K | 1.00K | F | Common Stock | -156.49K |
2024-02-12 | 2024-02-08 | Hait William | See Remarks | 34.50K | 3.06K | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Schmid Timothy | EVP, WW Chair, MedTech | 10.94K | 1.96K | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Broadhurst Vanessa | EVP, Global Corp Affairs | 20.38K | 703 | F | Common Stock | -109.90K |
2024-02-12 | 2024-02-08 | Broadhurst Vanessa | EVP, Global Corp Affairs | 21.08K | 1.88K | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Swanson James D. | See Remarks | 10.56K | 554 | F | Common Stock | -86.61K |
2024-02-12 | 2024-02-08 | Swanson James D. | See Remarks | 11.11K | 1.87K | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Decker Robert J | VP Corporate Controller | 17.36K | 215 | F | Common Stock | -33.61K |
2024-02-12 | 2024-02-08 | Forminard Elizabeth | Executive VP, General Counsel | 6.10K | 363 | F | Common Stock | -56.75K |
2024-02-12 | 2024-02-08 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 66.90K | 1.01K | F | Common Stock | -157.74K |
2024-02-12 | 2024-02-08 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 67.90K | 1.97K | M | Common Stock | 0 |
2024-02-12 | 2024-02-09 | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 141.42K | 59.40K | S | Common Stock | -9.28M |
2024-02-12 | 2024-02-09 | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 200.81K | 59.40K | M | Common Stock | 5.37M |
2024-02-12 | 2024-02-08 | Duato Joaquin | CEO and Chairman of the Board | 310.58K | 5.22K | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Wolk Joseph J | Exec VP, CFO | 52.86K | 1.05K | F | Common Stock | -163.68K |
2024-02-12 | 2024-02-08 | Decker Robert J | VP Corporate Controller | 17.57K | 655 | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Wolk Joseph J | Exec VP, CFO | 53.91K | 3.69K | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Duato Joaquin | CEO and Chairman of the Board | 308.31K | 2.27K | F | Common Stock | -354.71K |
2024-02-12 | 2024-02-08 | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 143.33K | 3.74K | M | Common Stock | 0 |
2024-02-12 | 2024-02-08 | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 141.42K | 1.91K | F | Common Stock | -299.06K |
2024-02-12 | 2024-02-08 | Fasolo Peter | Exec VP, Chief HR Officer | 103.68K | 781 | F | Common Stock | -122.09K |
2024-02-12 | 2024-02-08 | Fasolo Peter | Exec VP, Chief HR Officer | 104.47K | 2.13K | M | Common Stock | 0 |
2023-07-27 | 2023-07-26 | Hait William | See Remarks | 102.44K | 14.70K | M | Common Stock | 1.33M |
2023-07-27 | 2023-07-26 | Hait William | See Remarks | 87.75K | 14.70K | S | Common Stock | -2.53M |
2023-07-27 | 2023-07-25 | Fasolo Peter | Exec VP, Chief HR Officer | 102.70K | 20K | S | Common Stock | -3.41M |
2023-06-14 | 2023-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 65.93K | 12.46K | S | Common Stock | -1.99M |
2023-05-25 | 2023-05-24 | Wolk Joseph J | Exec VP, CFO | 50.34K | 55 | G | Common Stock | 0 |
2023-03-08 | 2023-03-06 | Swanson James D. | See Remarks | 9.22K | 1.06K | S | Common Stock | -164.20K |
2023-02-15 | 2023-02-13 | Forminard Elizabeth | Executive VP, General Counsel | 5.48K | 924 | F | Common Stock | -149.70K |
2023-02-15 | 2023-02-13 | Forminard Elizabeth | Executive VP, General Counsel | 6.41K | 2.56K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Hait William | See Remarks | 87.75K | 4.59K | F | Common Stock | -742.98K |
2023-02-15 | 2023-02-13 | Hait William | See Remarks | 92.33K | 9.64K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Broadhurst Vanessa | EVP, Global Corp Affairs | 19.20K | 1.44K | F | Common Stock | -233.29K |
2023-02-15 | 2023-02-13 | Broadhurst Vanessa | EVP, Global Corp Affairs | 20.64K | 3.98K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Swanson James D. | See Remarks | 10.28K | 918 | F | Common Stock | -148.73K |
2023-02-15 | 2023-02-13 | Swanson James D. | See Remarks | 11.20K | 3.23K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Mongon Thibaut | Exec VP, WW Chair, Cons Health | 72.35K | 13.71K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Decker Robert J | VP Corporate Controller | 16.92K | 397 | F | Common Stock | -64.32K |
2023-02-15 | 2023-02-13 | Mongon Thibaut | Exec VP, WW Chair, Cons Health | 65.92K | 6.43K | F | Common Stock | -1.04M |
2023-02-15 | 2023-02-13 | Decker Robert J | VP Corporate Controller | 17.31K | 1.45K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 78.40K | 4.89K | F | Common Stock | -792.39K |
2023-02-15 | 2023-02-13 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 83.29K | 10.84K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 139.59K | 10.57K | F | Common Stock | -1.71M |
2023-02-15 | 2023-02-13 | Mcevoy Ashley | EVP, WW Chair, MedTech | 54.82K | 7.16K | F | Common Stock | -1.16M |
2023-02-15 | 2023-02-13 | Mcevoy Ashley | EVP, WW Chair, MedTech | 61.98K | 17.99K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 150.16K | 21.42K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Wolk Joseph J | Exec VP, CFO | 50.40K | 8.58K | F | Common Stock | -1.39M |
2023-02-15 | 2023-02-13 | Wolk Joseph J | Exec VP, CFO | 58.98K | 20.69K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Duato Joaquin | CEO and Chairman of the Board | 316.39K | 13.60K | F | Common Stock | -2.20M |
2023-02-15 | 2023-02-13 | Duato Joaquin | CEO and Chairman of the Board | 329.99K | 31.32K | A | Common Stock | 0 |
2023-02-15 | 2023-02-13 | Fasolo Peter | Exec VP, Chief HR Officer | 122.70K | 5.76K | F | Common Stock | -933.99K |
2023-02-15 | 2023-02-13 | Fasolo Peter | Exec VP, Chief HR Officer | 128.46K | 12.47K | A | Common Stock | 0 |
2022-12-15 | 2022-12-13 | Wolk Joseph J | Exec VP, CFO | 48.74K | 1.85K | S | Common Stock | -332.91K |
2022-12-15 | 2022-12-13 | Wolk Joseph J | Exec VP, CFO | 50.59K | 1.85K | M | Common Stock | 134.56K |
2022-12-15 | 2022-12-13 | Wolk Joseph J | Exec VP, CFO | 35.81K | 12.93K | S | Common Stock | -2.32M |
2022-12-15 | 2022-04-20 | Wolk Joseph J | Exec VP, CFO | 35.81K | 28 | G | Common Stock | 0 |
2022-12-15 | 2022-04-20 | Wolk Joseph J | Exec VP, CFO | 35.84K | 18 | G | Common Stock | 0 |
2022-12-15 | 2022-12-13 | Wolk Joseph J | Exec VP, CFO | 48.74K | 12.93K | M | Common Stock | 1.17M |
2022-12-02 | 2022-11-30 | Mcevoy Ashley | EVP, WW Chair, MedTech | 115.14K | 73.32K | M | Common Stock | 5.32M |
2022-12-02 | 2022-11-30 | Mcevoy Ashley | EVP, WW Chair, MedTech | 113.74K | 1.40K | S | Common Stock | -246.53K |
2022-12-02 | 2022-11-30 | Mcevoy Ashley | EVP, WW Chair, MedTech | 41.81K | 71.92K | S | Common Stock | -12.62M |
2022-11-10 | 2022-11-09 | Wengel Kathryn E | EVP, Chief GSC Officer | 71.31K | 16.41K | S | Common Stock | -2.85M |
2022-11-10 | 2022-11-09 | Wengel Kathryn E | EVP, Chief GSC Officer | 87.72K | 16.41K | M | Common Stock | 1.19M |
2022-11-09 | 2022-11-07 | Mongon Thibaut | Exec VP, WW Chair, Consumer | 57.18K | 7.01K | M | Common Stock | 714.11K |
2022-11-09 | 2022-11-07 | Mongon Thibaut | Exec VP, WW Chair, Consumer | 50.17K | 10.03K | M | Common Stock | 1.16M |
2022-11-08 | 2022-11-04 | Mongon Thibaut | Exec VP, WW Chair, Consumer | 58.43K | 16.95K | S | Common Stock | -2.90M |
2022-11-08 | 2022-11-04 | Mongon Thibaut | Exec VP, WW Chair, Consumer | 75.38K | 16.95K | M | Common Stock | 2.20M |
2022-11-08 | 2022-11-04 | Mongon Thibaut | Exec VP, WW Chair, Consumer | 40.13K | 18.29K | S | Common Stock | -3.13M |
2022-11-08 | 2022-11-04 | Mongon Thibaut | Exec VP, WW Chair, Consumer | 58.43K | 18.29K | M | Common Stock | 2.41M |
2022-11-04 | 2022-11-02 | Swanson James D. | EVP, Chief Information Officer | 7.06K | 3.93K | F | Common Stock | -677.44K |
2022-11-04 | 2022-11-02 | Swanson James D. | EVP, Chief Information Officer | 11.00K | 9.91K | M | Common Stock | 0 |